ABSTRACT:
Diabetes could be a chronic, metabolic illness characterised by elevated levels of blood sugar, that leads over time to serious harm to the guts, blood vessels, eyes, kidneys, and nerves. The foremost common is type two polygenic disease, typically in adults, that happens once the body becomes immune to hypoglycemic agent or does not build enough hypoglycemic agent. Within the past 3 decades the prevalence of type two polygenic disease has up dramatically in countries of all financial gain levels. The main aim of the study provides overview prevalence, drug utilization by using WHO-INRUD (International Network of Rational Use of Drugs) drug core indicators in diabetic patients at tertiary care hospital. The drug utilization studies are focused to study prescription habits of medical practitioners. These studies aims to analyse the type of drugs prescribed, their dosing schedule, and the adequacy of the prescription for a specific diagnosis. The obtained data during the ward rounds were thoroughly analysed to evaluate rationality in drug using. In our study a total of 100 prescriptions were analysed and the most prescribed therapy was Insulin therapy (63%). When coming to oral hypoglycaemic drugs Sulphonylureas (7%) and Biguanides (7%) were more frequently prescribed which indicates their significant role in pharmacotherapy of diabetes, most of the prescriptions were prescribed in combinations in which dual therapy (87%) was most prescribed followed by triple therapy (13%). All the prescriptions were analysed for their compliance to WHO drug core indicators. The results implies that there is an increased need for prescribing generically as it is cost effective and has less potential for errors. Therefore it is advisable for all prescribers to prescribe generically.